← All trials
NCT01355575
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2011
- Primary completion
- Sep 1, 2012
- Completion date
- Sep 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- University of LondonOverall official - principal investigator
- University of LondonStudy chair
- National Health Service, United KingdomCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.